Norges Bank’s Niagen Bioscience NAGE Stock Holding History

Norges Bank’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-555,800	Closed	-$5.19M	–	2266
2021 Q1	$5.19M	Buy	+555,800	New	+$4.41M	﹤0.01%	1906

Other funds holding NAGE

YRHAM

Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank's NAGE Position: Q2 2021 in Review

Norges Bank sold out of Niagen Bioscience (NAGE) in Q2 2021, closing a stake of 555,800 shares — an estimated $5.19M sold.

Norges Bank first reported a position in NAGE in Q1 2021 and held it in 1 quarter. The position peaked at $5.19M in Q1 2021. 101 funds tracked by Wall St. Rank hold NAGE as of Q2 2021.

Norges Bank reported no remaining Niagen Bioscience position as of Q2 2021 after selling out during the quarter.
Norges Bank sold 555,800 Niagen Bioscience shares in Q2 2021, an estimated $5.19M.
Norges Bank first reported a position in Niagen Bioscience in Q1 2021 and held it in 1 quarter.
Norges Bank's Niagen Bioscience position peaked at $5.19M in Q1 2021.
101 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2021.

Based on Norges Bank's 13F filing for Q2 2021, filed 10 Aug 2021.